Cloning and characterization of NEU2, a human gene homologous to rodent soluble sialidases.

Sialidases (EC 3.2.1.18) are a group of glycohydrolytic enzymes, widely distributed in nature, that cleave sialic acid residues from the oligosaccharide components of glycoconjugates. All of the sialidase enzymes thus far characterized share an Asp block, repeated three to five times in the primary structure, and an F/YRIP sequence motif that is part of the active site. Using a sequence homology-based approach, we have identified a novel human gene, named NEU2, mapping to chromosome 2q37. The nucleotide sequence analysis of the gene has shown that it contains only one intron of about 1.25 kb, and the longest open reading frame encodes a protein of 380 amino acids, with a two-Asp block consensus, and the YRIP sequence. In the putative promoter sequence there are a classical TATAA box and four E boxes, which are consensus binding sites for muscle-specific transcription factors. Northern blot analysis revealed expression of the NEU2 transcript only in skeletal muscle.

[1]  H. Kawasaki,et al.  Molecular cloning and expression of cDNA encoding rat skeletal muscle cytosolic sialidase. , 1993, The Journal of biological chemistry.

[2]  J. Sambrook,et al.  Molecular Cloning: A Laboratory Manual , 2001 .

[3]  T. Werner,et al.  MatInd and MatInspector: new fast and versatile tools for detection of consensus matches in nucleotide sequence data. , 1995, Nucleic acids research.

[4]  J. Mar,et al.  M-CAT binding factor, a novel trans-acting factor governing muscle-specific transcription , 1990, Molecular and cellular biology.

[5]  M. Sliwkowski,et al.  Isolation and properties of a soluble sialidase from the culture fluid of Chinese hamster ovary cells. , 1993, Glycobiology.

[6]  M. Zeigler,et al.  The identification of lysosomal ganglioside sialidase in human cells. , 1989, European journal of biochemistry.

[7]  K. Sato,et al.  Genomic organization and the 5'-upstream sequence of the rat cytosolic sialidase gene. , 1995, Glycobiology.

[8]  J. Gilbert,et al.  Evidence for locus heterogeneity in the Bethlem myopathy and linkage to 2q37. , 1996, Human molecular genetics.

[9]  A. Rosenberg Biology of the Sialic Acids , 1995, Springer US.

[10]  M. Kozak The scanning model for translation: an update , 1989, The Journal of cell biology.

[11]  R. Campbell,et al.  Identification of a Sialidase Encoded in the Human Major Histocompatibility Complex* , 1997, The Journal of Biological Chemistry.

[12]  R. Yu,et al.  Biochemistry and Function of Sialidases , 1995 .

[13]  M. Fornerod,et al.  Characterization of human lysosomal neuraminidase defines the molecular basis of the metabolic storage disorder sialidosis. , 1996, Genes & development.

[14]  J. Thompson,et al.  CLUSTAL W: improving the sensitivity of progressive multiple sequence alignment through sequence weighting, position-specific gap penalties and weight matrix choice. , 1994, Nucleic acids research.

[15]  J. Klein,et al.  Evidence for placing the Neu-1 locus within the mouse H-2 complex. , 1982, Journal of immunology.

[16]  M. Kozak An analysis of 5'-noncoding sequences from 699 vertebrate messenger RNAs. , 1987, Nucleic acids research.

[17]  T. Warner,et al.  Cloning and expression of a soluble sialidase from Chinese hamster ovary cells: sequence alignment similarities to bacterial sialidases. , 1994, Glycobiology.

[18]  S. Kelm,et al.  Biochemistry and Role of Sialic Acids , 1995 .

[19]  C. Siniscalco,et al.  Solubilization of the Membrane‐Bound Sialidase from Pig Brain by Treatment with Bacterial Phosphatidylinositol Phospholipase C , 1990, Journal of neurochemistry.

[20]  H. Galjaard,et al.  Human placental neuraminidase , 1985 .

[21]  C. Scriver,et al.  The Metabolic and Molecular Bases of Inherited Disease, 8th Edition 2001 , 2001, Journal of Inherited Metabolic Disease.

[22]  T Corfield,et al.  Bacterial sialidases--roles in pathogenicity and nutrition. , 1992, Glycobiology.

[23]  S. Tsuiki,et al.  Rat-liver lysosomal sialidase. Solubilization, substrate specificity and comparison with the cytosolic sialidase. , 1984, European journal of biochemistry.

[24]  S. McKnight,et al.  Transcriptional control signals of a eukaryotic protein-coding gene. , 1982, Science.

[25]  H. Gabius,et al.  Sialic acids structure-analysis-metabolism-occurrence-recognition. , 1996, Biological chemistry Hoppe-Seyler.

[26]  C. Marck,et al.  'DNA Strider': a 'C' program for the fast analysis of DNA and protein sequences on the Apple Macintosh family of computers. , 1988, Nucleic acids research.

[27]  B. Nadal-Ginard,et al.  Human myocyte-specific enhancer factor 2 comprises a group of tissue-restricted MADS box transcription factors. , 1992, Genes & development.

[28]  P. Mandel,et al.  Sub-synaptosomal localization of brain particulate neuraminidose. , 1972, Brain research.

[29]  J. Ragoussis,et al.  Map of the human MHC. , 1991, Immunology today.

[30]  Gregory D. Schuler,et al.  ESTablishing a human transcript map , 1995, Nature Genetics.

[31]  K. Sato,et al.  Involvement of an endogenous sialidase in skeletal muscle cell differentiation. , 1996, Biochemical and biophysical research communications.

[32]  W. Rutter,et al.  Isolation of biologically active ribonucleic acid from sources enriched in ribonuclease. , 1979, Biochemistry.

[33]  S. Tsuiki,et al.  Immunological discrimination of intralysosomal, cytosolic, and two membrane sialidases present in rat tissues. , 1990, Journal of biochemistry.

[34]  C. Sweeley,et al.  Sialidase activities of cultured human fibroblasts and the metabolism of GM3 ganglioside. , 1988, The Journal of biological chemistry.

[35]  E. Olson,et al.  bHLH factors in muscle development: dead lines and commitments, what to leave in and what to leave out. , 1994, Genes & development.

[36]  M. Adams,et al.  Toward a cDNA map of the human genome. , 1995, Genomics.

[37]  Thomas L. Madden,et al.  Gapped BLAST and PSI-BLAST: a new generation of protein database search programs. , 1997, Nucleic acids research.

[38]  David Baltimore,et al.  A new DNA binding and dimerization motif in immunoglobulin enhancer binding, daughterless, MyoD, and myc proteins , 1989, Cell.

[39]  Daniel Leclerc,et al.  Cloning, expression and chromosomal mapping of human lysosomal sialidase and characterization of mutations in sialidosis , 1997, Nature Genetics.

[40]  M. Pericak-Vance,et al.  Missense mutation in a von Willebrand factor type A domain of the alpha 3(VI) collagen gene (COL6A3) in a family with Bethlem myopathy. , 1998, Human molecular genetics.

[41]  S. Tsuiki,et al.  Purification and characterization of cytosolic sialidase from rat liver. , 1985, The Journal of biological chemistry.